India has witnessed over 10 million COVID cases to date, which also includes 150,000 deaths since the first infection in the country was detected in the southern state.
December 30, 2020
Mahindra Group Chairman Anand Mahindra×
Tags Health Minister Dr Harsh Vardhan to tweet ‘Trust India will waste no time in approval’ Mahindra Group Chairman Anand Mahindra lauded the approval of AstraZeneca-Oxford University’s Covid-19 vaccine for emergency supply in the United Kingdom.
Mahindra took to Twitter to hail the news. Tagging Health Minister Dr Harsh Vardhan on the post, he tweeted, “Light at the end of the tunnel. I trust India will waste no time in approval as well.. @drharshvardhan.”
Mahindra in November had hailed AstraZeneca’s announcement of successful interim trials for its Covid-19 vaccine candidate.
He shared his thoughts on Twitter stating that the vaccine candidate from the company could be one of the best bets for India in combatting the pandemic.
Last Updated:
Latest News: Rajnath Singh Warns China; Vardhan Nominated To GAVI Board; Ex-Pak FM Held
From Health Minister Dr Harsh Vardhan being nominated to be a board member at GAVI to Defence Minister Rajnath Singh warning China, read latest news at 10 AM.
Health Minister Dr Harsh Vardhan Nominated To Global Vaccine Alliance Board
Union Health Minister Dr Harsh Vardhan has been nominated to be a board member at the Global Alliance for Vaccines and Immunisation (GAVI), said Ministry of Health and Family Welfare. Dr Harsh Vardhan will be representing the South East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board from January 1, 2021, until December 31, 2023. At present, the seat is held by Myint Htwe of Myanmar.
India is considering three coronavirus vaccines for emergency use authorisation (File)
New Delhi:
Existing coronavirus vaccines will work against mutated strains of the virus that have emerged from the United Kingdom and South Africa in recent months, the Health Ministry said at its Tuesday briefing.
The ministry was responding to fears the first lot of vaccines will be ineffective against aggressive variants of a virus that has already infected over a crore and killed 1.5 lakh people in India alone. There is no evidence current vaccines will fail to protect against COVID-19 variants from the UK or South Africa, Professor K VijayRaghavan, the government s Principal Scientific Adviser, said.